Publications

Guidance for male mentors to support the safety and success of female mentees

Hill LG, Laguado SA.

Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas

Evoy KE, Groff L, Hill LG, Godinez W, Gandhi R, Reveles KR.

Implementation of a collaborative model for opioid overdose prevention on campus

Hill LG, Holleran Steiker LK, Mazin L, Kinzly ML.

Development of a health communication campaign to promote the Texas prescription monitoring program

Mackert M, Pounders K, Brown L, Kirtz S, Hughes Wagner J, Ring D, Hill LG, Wilcox G, Murthy D, Tierney W, Innerarity S, McGlone M, Holleran Steiker LK, DeSalvo K, Bernhardt J, Pretorius K.

Reply to a letter regarding, “Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction”

Hill LG, Evoy KE, Reveles KR.

Isotonitazene as a contaminant of concern in the illegal opioid supply: A practical synthesis and cost perspective

Zagorski CM, Myslinski JM, Hill LG.

Lofexidine for acute opioid withdrawal: A clinical case series

Renfro ML, Loera LJ, Tirado CF, Hill LG.

Type and extent of opioid-related education provided by U.S. college of pharmacy continuing education divisions

Renfro ML, Moczygemba LR, Baumgartner J, Baumgart G, Hill LG.

Increasing naloxone knowledge and use through direct-to-patient education

Litten K, Hill LG, Garza A, Srinivasa M.

Report of the 2020 special committee on substance use and pharmacy education

Tran T, Ball J, Bratberg JP, DeSimone EM, Franko TS, Hill LG, Koh-Knox Sharp CP, Palombi L, Ventricelli D, Farrell D, Gandhi N, Moore T.